BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38103364)

  • 21. Regulation of mTOR signaling by long non-coding RNA.
    Aboudehen K
    Biochim Biophys Acta Gene Regul Mech; 2020 Apr; 1863(4):194449. PubMed ID: 31751821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging Roles of Long non-coding RNAs in The Tumor Microenvironment.
    Zhou L; Zhu Y; Sun D; Zhang Q
    Int J Biol Sci; 2020; 16(12):2094-2103. PubMed ID: 32549757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy.
    Chen JF; Wu P; Xia R; Yang J; Huo XY; Gu DY; Tang CJ; De W; Yang F
    Mol Cancer; 2018 Jan; 17(1):6. PubMed ID: 29329543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H; Pu J; Zhou XL; Ning YY; Bai C
    Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unravelling the role of long non-coding RNAs in modulating the Hedgehog pathway in cancer.
    Chandel SS; Mishra A; Dubey G; Singh RP; Singh M; Agarwal M; Chawra HS; Kukreti N
    Pathol Res Pract; 2024 Feb; 254():155156. PubMed ID: 38309021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long noncoding RNA KB-1460A1.5 inhibits glioma tumorigenesis via miR-130a-3p/TSC1/mTOR/YY1 feedback loop.
    Xu L; Wu Q; Yan H; Shu C; Fan W; Tong X; Li Q
    Cancer Lett; 2022 Jan; 525():33-45. PubMed ID: 34728310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Highly expressed long non-coding RNA CRNDE promotes cell proliferation through PI3K/AKT signalling in non-small cell lung carcinoma.
    Liu XX; Xiong HP; Huang JS; Qi K; Xu JJ
    Clin Exp Pharmacol Physiol; 2017 Aug; 44(8):895-902. PubMed ID: 28477368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-talk between non-coding RNAs and PI3K/AKT/mTOR pathway in colorectal cancer.
    Moafian Z; Maghrouni A; Soltani A; Hashemy SI
    Mol Biol Rep; 2021 May; 48(5):4797-4811. PubMed ID: 34057685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
    Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
    Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosomal long noncoding RNAs MAGI2-AS3 and CCDC144NL-AS1 in oral squamous cell carcinoma development via the PI3K-AKT-mTOR signaling pathway.
    Li C; Guo H; Xiong J; Feng B; Zhu P; Jiang W; Jiang P; Su X; Huang X
    Pathol Res Pract; 2022 Dec; 240():154219. PubMed ID: 36401978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ARID3A and ARID3B exert direct regulatory control over the long non-coding RNAs (lncRNAs) MALAT1 and NORAD within the context of non-small cell lung cancer (NSCLC).
    Nasuh S; Balci SO; Bozgeyik I; Ikeda MA; Tekayev M; Saadat KASM
    Pathol Res Pract; 2023 Dec; 252():154948. PubMed ID: 37977034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long noncoding RNA BFAL1 mediates enterotoxigenic Bacteroides fragilis-related carcinogenesis in colorectal cancer via the RHEB/mTOR pathway.
    Bao Y; Tang J; Qian Y; Sun T; Chen H; Chen Z; Sun D; Zhong M; Chen H; Hong J; Chen Y; Fang JY
    Cell Death Dis; 2019 Sep; 10(9):675. PubMed ID: 31515468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRNDE, a long non-coding RNA responsive to insulin/IGF signaling, regulates genes involved in central metabolism.
    Ellis BC; Graham LD; Molloy PL
    Biochim Biophys Acta; 2014 Feb; 1843(2):372-86. PubMed ID: 24184209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of key lncRNAs in colorectal cancer progression based on associated protein-protein interaction analysis.
    Zhu H; Yu J; Zhu H; Guo Y; Feng S
    World J Surg Oncol; 2017 Aug; 15(1):153. PubMed ID: 28797257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NEAT1 mediates paclitaxel-resistance of non-small cell of lung cancer through activation of Akt/mTOR signalling pathway.
    Li B; Gu W; Zhu X
    J Drug Target; 2019 Dec; 27(10):1061-1067. PubMed ID: 30782035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway.
    Yu T; Zhao Y; Hu Z; Li J; Chu D; Zhang J; Li Z; Chen B; Zhang X; Pan H; Li S; Lin H; Liu L; Yan M; He X; Yao M
    Cancer Res; 2017 Nov; 77(21):5782-5794. PubMed ID: 28923857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PI3K/AKT/mTOR pathway-related long non-coding RNAs: roles and mechanisms in hepatocellular carcinoma.
    Wu Y; Zhang Y; Qin X; Geng H; Zuo D; Zhao Q
    Pharmacol Res; 2020 Oct; 160():105195. PubMed ID: 32916254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNAs: an overview on miRNA sponging and its co-regulation in lung cancer.
    Rajakumar S; Jamespaulraj S; Shah Y; Kejamurthy P; Jaganathan MK; Mahalingam G; Ramya Devi KT
    Mol Biol Rep; 2023 Feb; 50(2):1727-1741. PubMed ID: 36441373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma.
    Pan J; Huang Z; Lin H; Cheng W; Lai J; Li J
    BMC Cancer; 2022 Nov; 22(1):1132. PubMed ID: 36333719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-coding RNA profile in lung cancer.
    Ghafouri-Fard S; Shoorei H; Branicki W; Taheri M
    Exp Mol Pathol; 2020 Jun; 114():104411. PubMed ID: 32112788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.